[HTML][HTML] A deep learning system to screen novel coronavirus disease 2019 pneumonia
X Xu, X Jiang, C Ma, P Du, X Li, S Lv, L Yu, Q Ni… - Engineering, 2020 - Elsevier
The real-time reverse transcription-polymerase chain reaction (RT-PCR) detection of viral
RNA from sputum or nasopharyngeal swab had a relatively low positive rate in the early stage …
RNA from sputum or nasopharyngeal swab had a relatively low positive rate in the early stage …
[PDF][PDF] Towards an artificial intelligence framework for data-driven prediction of coronavirus clinical severity
The virus SARS-CoV2, which causes coronavirus disease (COVID-19) has become a pandemic
and has spread to every inhabited continent. Given the increasing caseload, there is an …
and has spread to every inhabited continent. Given the increasing caseload, there is an …
[HTML][HTML] Lactate dehydrogenase and susceptibility to deterioration of mild COVID-19 patients: a multicenter nested case-control study
J Shi, Y Li, X Zhou, Q Zhang, X Ye, Z Wu, X Jiang, H Yu… - BMC medicine, 2020 - Springer
Background Coronavirus disease 2019 (COVID-19) has infected more than 4 million people
within 4 months. There is an urgent need to properly identify high-risk cases that are more …
within 4 months. There is an urgent need to properly identify high-risk cases that are more …
[HTML][HTML] COVID‐19 in Tuberculosis patients: a report of three cases
…, J Wu, J Shi, J Dai, M Gamber, X Jiang… - Journal of medical …, 2020 - ncbi.nlm.nih.gov
To the Editor, The World Health Organization declared the outbreak of novel coronavirus
disease 2019 (COVID‐19) a Public Health Emergency of International on 30 January 2020. 1 It …
disease 2019 (COVID‐19) a Public Health Emergency of International on 30 January 2020. 1 It …
[HTML][HTML] Psychological morbidities and fatigue in patients with confirmed COVID-19 during disease outbreak: prevalence and associated biopsychosocial risk factors
…, W Surento, S Luo, ZY Sun, CS Zhou, L Li, X Jiang… - MedRxiv, 2020 - ncbi.nlm.nih.gov
Objective: The coronavirus disease 2019 (COVID-19)-a novel and highly infectious
pneumonia-has now spread across China and beyond for over four months. However, its …
pneumonia-has now spread across China and beyond for over four months. However, its …
Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series
XW Xu, XX Wu, XG Jiang, KJ Xu, LJ Ying, CL Ma, SB Li… - bmj, 2020 - bmj.com
Objective To study the clinical characteristics of patients in Zhejiang province, China, infected
with the 2019 severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) responsible …
with the 2019 severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) responsible …
[HTML][HTML] Oral VV116 versus placebo in patients with mild-to-moderate COVID-19 in China: a multicentre, double-blind, phase 3, randomised controlled study
…, W Li, Q Wang, X Wang, Y Bai, X Jiang… - The Lancet Infectious …, 2024 - thelancet.com
Background Spread of SARS-CoV-2 led to a global pandemic, and there remains unmet
medical needs in the treatment of Omicron infections. VV116, an oral antiviral agent that has …
medical needs in the treatment of Omicron infections. VV116, an oral antiviral agent that has …
[HTML][HTML] SNHG20 knockdown suppresses proliferation, migration and invasion, and promotes apoptosis in non-small cell lung cancer through acting as a miR-154 …
J Lingling, J Xiangao, H Guiqing, S Jichan… - Biomedicine & …, 2019 - Elsevier
Long noncoding RNAs (LncRNAs) play critical roles in the development and progression of
cancers. However, little is known about the function and mechanism of lncRNAs in non-small …
cancers. However, little is known about the function and mechanism of lncRNAs in non-small …
Introducing molecular testing of pyrazinamide susceptibility improves multidrug-resistant tuberculosis treatment outcomes: a prospective cohort study
F Sun, Y Li, Y Chen, W Guan, X Jiang… - European …, 2019 - Eur Respiratory Soc
The current treatment for multidrug-resistant tuberculosis (MDR-TB) takes a lengthy period of
18–24 months and has a poor cure rate of 50–60%. A multicenter, prospective cohort study …
18–24 months and has a poor cure rate of 50–60%. A multicenter, prospective cohort study …
[HTML][HTML] Application of matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) in the detection of drug resistance of …
J Shi, G He, H Ning, L Wu, Z Wu, X Ye, C Qiu, X Jiang - Tuberculosis, 2022 - Elsevier
Objective To evaluate the value of matrix-assisted laser desorption ionization time-of-flight
mass spectrometry (MALDI-TOF MS) in the detection of drug resistance of Mycobacterium …
mass spectrometry (MALDI-TOF MS) in the detection of drug resistance of Mycobacterium …
